Jul 31, 2025 · SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5000)
Lobbying reported · America's Health Insurance Plans (ahip) · Jul 20America's Health Insurance Plans (ahip) reported 2nd Quarter (Apr 1 - June 30) lobbying for America's Health Insurance Plans (ahip) — $3,010,000BillsH.R. 1H.R. 247H.R. 379H.R. 584H.R. 608H.R. 610H.R. 842H.R. 935H.R. 950H.R. 957H.R. 1096H.R. 1117H.R. 1157H.R. 1162H.R. 1397H.R. 1403H.R. 1523H.R. 1614H.R. 1627H.R. 1775H.R. 1776H.R. 1805H.R. 1867H.R. 1899H.R. 1924H.R. 2013H.R. 2045H.R. 2049H.R. 2079H.R. 2199H.R. 2309H.R. 2433H.R. 2450H.R. 2528H.R. 2533H.R. 2553H.R. 2554H.R. 2571H.R. 2586H.R. 2610H.R. 2636H.R. 2741H.R. 3000H.R. 3023H.R. 3069H.R. 3415H.R. 3493H.R. 3527H.R. 3546H.R. 3701H.R. 3789H.R. 3808H.R. 4093H.R. 4206H.R. 4231H.R. 4313H.R. 4317H.R. 4406H.R. 4559H.R. 4605H.R. 4623H.R. 4641H.R. 4710H.R. 5081H.R. 5145H.R. 5243H.R. 5281H.R. 5371H.R. 5509H.R. 5526H.R. 5582H.R. 5584H.R. 6010H.R. 6232H.R. 6248H.R. 6255H.R. 6361H.R. 6703H.R. 6951H.R. 6974H.R. 7023H.R. 7064H.R. 7164H.R. 7189H.R. 7409H.R. 7537H.R. 7727H.R. 7778H.R. 7787H.R. 7790H.R. 7803H.R. 7837H.R. 7871H.R. 8270H.R. 8375H.R. 8377H.R. 8684H.R. 8779H.R. 8875H.R. 9393H.R. 9504S. 339S. 483S. 526S. 529S. 652S. 717S. 729S. 752S. 864S. 882S. 891S. 931S. 939S. 976S. 1040S. 1056S. 1082S. 1096S. 1227S. 1261S. 1637S. 1753S. 1816S. 1818S. 1847S. 1954S. 1973S. 2237S. 2289S. 2345S. 2355S. 2356S. 2497S. 2556S. 2620S. 2658S. 2709S. 2903S. 3014S. 3599S. 3642S. 3690S. 3727S. 3729S. 3750S. 3751S. 3762S. 3822S. 3829S. 3834S. 3848S. 3886S. 3990S. 4189S. 4332S. 4355S. 4384S. 4509S. 4512
Lobbying reported · Kaiser Foundation Health Plan · Jul 20Kaiser Foundation Health Plan reported 2nd Quarter (Apr 1 - June 30) lobbying for Kaiser Foundation Health Plan — $530,000BillsH.R. 3269H.R. 3514H.R. 5429H.R. 5526H.R. 5582H.R. 6248H.R. 6644H.R. 7148H.R. 8800H.R. 9393H.R. 9504S. 43S. 1816S. 1954S. 2355S. 2620S. 2780S. 3014S. 3822S. 4027S. 4784
Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5371H.R. 6089H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.R. 9661H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 1040S. 1071S. 1096S. 1387S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · Glaxosmithkline · Jul 16Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5509H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7391H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 891S. 1040S. 1071S. 1096S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784